IMR Press / FBL / Volume 10 / Issue 2 / DOI: 10.2741/1623

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with Frontiers in Bioscience.

Open Access Article
Role of calcium-containing crystals in osteoarthritis
Show Less
1 Miami VA Medical Center and Dept. of Biomedical Engineering, University of Miami, 1201 N.W. 16th St. Miami, FL 33125, USA

Academic Editor: Yubo Sun

Front. Biosci. (Landmark Ed) 2005, 10(2), 1336–1340;
Published: 1 May 2005
(This article belongs to the Special Issue Crystals-associated arthropathies and therapeutic development)

The deposition of calcium-containing crystals in articular tissues is probably an underrecognized event. Clinical observations indicate that exaggerated and uniquely distributed cartilage degeneration is associated with these deposits. Perhaps the most compelling argument favoring a role for crystals in causing osteoarthritis stems from their in vitro effects on articular tissues. In this review, we will highlight some of the recent findings that further reinforce the thesis that basic calcium phosphate (BCP) and calcium pyrophosphate dihydrate (CPPD) crystals can cause the degeneration of articular tissues in 2 separate pathways. In the "Direct" pathway, crystals directly induce fibro-blast-like synoviocytes to proliferate and produce metalloproteinases and prostaglandins. The other "Paracrine Pathway" involves the interaction between crystals and macrophages/monocytes which leads to synthesis and release of cytokines which can reinforce the action of crystals on synoviocytes and/or induce chondrocytes to secrete enzymes and which eventually cause the degeneration of articular tissues.

BCP crystals
CPPD Crystals
Matrix Metalloproteinases
Early Response Genes
Back to top